InsidersTradesSigma
Browse the detailed record of transactions filed by Dash Barry H, Director. Officer active across 1 companies, notably Elite Pharmaceuticals INC. Cumulatively, 2 disclosures have been published. The latest transaction was filed on 30 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Barry H. Dash is a Board Member at Elite Pharmaceuticals Inc. He plays a key role in overseeing the company's operations and strategic decision-making. With experience in the pharmaceutical sector, he contributes to the strategic direction of Elite Pharmaceuticals, which focuses on developing generic drugs.